IMFINZI 500 mg/10mL

IMFINZI 500 mg/10mL is a solution for intravenous use, containing durvalumab. This medication is used in cancer treatment to help the immune system fight cancer cells. It is manufactured by AstraZeneca Pharmaceuticals LP in the USA.

IMFINZI 500 mg/10mL is primarily used in cancer treatment. Durvalumab, the active ingredient, works by helping the immune system recognize and attack cancer cells. This medication is often used in combination with other treatments to enhance their effectiveness. It is important to consult with a healthcare provider to determine if this medication is suitable for your specific condition.

Common effects of IMFINZI 500 mg/10mL may include fatigue, nausea, and cough. Some patients may also experience skin reactions or changes in appetite. These effects can vary from person to person, and not everyone will experience them. If you have concerns about any effects, it is advisable to discuss them with your healthcare provider.

IMFINZI 500 mg/10mL should be handled with care and stored as directed. It is important to inform your healthcare provider about any allergies or medical conditions you have before starting this medication. This solution is for intravenous use only and should be administered by a healthcare professional. Always follow the instructions provided by your healthcare provider.

IMFINZI 500 mg/10mL may interact with other medications, including those that affect the immune system. It is important to inform your healthcare provider about all the medications you are taking, including prescription and over-the-counter drugs, as well as any herbal supplements. Alcohol and certain foods may also interact with this medication, so it is advisable to discuss any dietary restrictions with your healthcare provider.